NCT04330170 is a clinical trial in Deep Vein Thrombosis, Pulmonary Embolus, sponsored by Pirogov Russian National Research Medical University.

Who is sponsoring NCT04330170?

NCT04330170 is sponsored by Pirogov Russian National Research Medical University.

What condition does NCT04330170 study?

NCT04330170 studies Deep Vein Thrombosis, Pulmonary Embolus.

Is NCT04330170 still recruiting?

NCT04330170 is currently completed. Last updated 6 April 2020.

Last reviewed 2020-04-06 · How we verify

NCT04330170

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Inferior Vena Cava Filters: Analysis of a Database

Completed Last updated 6 April 2020

What this trial tests

trial in Deep Vein Thrombosis, Pulmonary Embolus in 2,399 participants. Completed in 28 March 2020.

Timeline

13 January 2016

Primary endpoint
28 March 2020

28 March 2020

Quick facts

Lead sponsor	Pirogov Russian National Research Medical University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	2,399
Start date	13 January 2016
Primary completion	28 March 2020
Estimated completion	28 March 2020
Sites	1 location across Russia

Conditions studied

Deep Vein Thrombosis, Pulmonary Embolus — all drugs for Deep Vein Thrombosis, Pulmonary Embolus →

Sponsor

Pirogov Russian National Research Medical University

Who can join

Adults 16 to 91, any sex, with Deep Vein Thrombosis, Pulmonary Embolus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study a retrospective analysis of patients database was performed, who underwent treatment for deep vein thrombosis in tertiary hospital by using inferior vena cava-filters

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Inferior vena cava filters: a framework for evidence-based use.
Kelkar AH, Rajasekhar A. · · 2020 · cited 24× · PMID 33275716 · DOI 10.1182/hematology.2020000149

Verify or expand the search:

Other Pirogov Russian National Research Medical University trials

Trials by the same sponsor.

NCT07449728 — The Influence of Laser Crossectomy With Different Wavelengths on Varicose Vein Progression · NA · recruiting
NCT07363603 — Tianasen (ASO-GNAO1) for GNAO1-Encephalopathy With Epilepsy and Movement Disorders. · Phase 1, PHASE2 · recruiting
NCT07083986 — Carotid Endarterectomy Versus Stenting in Patients With Acute Stage of Ischemic Stroke. · NA · enrolling by invitation
NCT06766968 — Prolonged Compression Following Foam Sclerotherapy · NA · active not recruiting
NCT06753786 — Timing of Venous Thromboembolism Prophylaxis in Patients With Hypertensive Intracerebral Hemorrhage · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04330170 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Pirogov Russian National Research Medical University
Last refreshed: 6 April 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04330170.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing